$24.01
0.763.27%
À la fermeture: -
$24.24
0.230.96%
Après les heures de négociation: Oct 31, 7:26 PM EDT
Suivez les dernières activités de délit d'initié Sarepta Therapeutics. Restez informé des achats, des ventes et de l'impact sur le marché des actions Sarepta Therapeutics.
L'activité de délit d'initié implique des initiés de l'entreprise, tels que des dirigeants, des administrateurs et des employés, qui s'engagent dans des transactions sur les actions de leur propre entreprise. Les transactions d'achat et de vente des initiés fournissent des informations précieuses sur leur confiance dans les performances futures de l'entreprise.
Les initiés n’ont signalé aucun achat/vente au cours des 30 derniers jours.
Il n’y a eu aucun achat ou vente d’initié au cours des 90 derniers jours.
Mar 13, 2025 | — | 7.25K | $62.41 | -$2.80K | SELL-OPTIONS | 35.29% | 27.81K | Mar 12 | ||
Dec 16, 2024 | — | 0.00 | $69.28 | -$1.17M | SELL-OPTIONS | 0.00% | 22.84K | Dec 12 | ||
Dec 06, 2024 | — | -1.64K | $125.55 | -$205.40K | SELL | -21.77% | 5.88K | Dec 05 | ||
Sep 03, 2024 | CHIEF FINANCIAL OFFICER | -5.99K | $137.36 | -$822.10K | SELL | -14.99% | 33.95K | Aug 30 | ||
Aug 20, 2024 | — | 37.04K | $133.80 | $4.96M | BUY | 14.51% | 292.31K | Aug 16 | ||
Jun 25, 2024 | EVP, GENERAL COUNSEL | -11.56K | $112.28 | -$5.21M | SELL | -40.29% | 17.13K | Jun 21 - Jun 25 | ||
Jun 25, 2024 | CHIEF TECH OPS OFFICER | -7.86K | $163.38 | -$2.31M | SELL | -31.16% | 17.36K | Jun 21 - Jun 25 | ||
May 06, 2024 | CHIEF CUSTOMER OFFICER | -3.63K | $140.00 | -$508.90K | SELL | -16.70% | 18.13K | May 02 | ||
Mar 11, 2024 | — | 0.00 | $68.58 | -$1.64M | SELL-OPTIONS | 0.00% | 22.84K | Mar 08 | ||
Mar 11, 2024 | — | -761.00 | $122.93 | -$93.55K | SELL | -9.19% | 7.52K | Mar 11 | ||
Mar 06, 2024 | — | -3.13K | $122.96 | -$385.48K | SELL | -32.13% | 6.62K | Mar 05 | ||
Mar 05, 2024 | CHIEF TECH OPS OFFICER | 3.63K | $128.43 | -$303.74K | GRANT | 15.74% | 26.72K | Mar 01 | ||
Mar 05, 2024 | CHIEF FINANCIAL OFFICER | 4.43K | $127.81 | -$200.02K | GRANT | 12.79% | 39.11K | Mar 01 | ||
Mar 05, 2024 | EVP, GENERAL COUNSEL | 3.73K | $125.44 | -$284.63K | GRANT | 13.28% | 31.83K | Mar 01 | ||
Nov 06, 2023 | DIRECTOR | 50.00K | $78.81 | $3.94M | BUY | 1.66% | 3.07M | Nov 03 | ||
Nov 06, 2023 | PRESIDENT & CEO | 25.23K | $79.36 | $2.00M | BUY | 6.91% | 390.31K | Nov 03 | ||
Aug 15, 2023 | DIRECTOR | 9.98K | $109.47 | $1.09M | BUY | 4.10% | 253.43K | Aug 14 | ||
Aug 14, 2023 | DIRECTOR | 23.69K | $108.05 | $2.56M | BUY | 10.78% | 243.45K | Aug 11 | ||
Aug 11, 2023 | DIRECTOR | 34.87K | $106.15 | $3.70M | BUY | 18.86% | 219.76K | Aug 10 | ||
Aug 08, 2023 | DIRECTOR | 0.00 | $67.88 | -$1.17M | SELL-OPTIONS | 0.00% | 20.99K | Aug 04 | ||
Nov 21, 2022 | DIRECTOR | -858.00 | $109.92 | -$94.31K | SELL | -11.84% | 6.39K | Nov 17 | ||
Sep 15, 2022 | DIRECTOR | 57.10K | $104.43 | $5.96M | BUY | 45.22% | 183.37K | Sep 14 | ||
Aug 22, 2022 | DIRECTOR | 46.17K | $108.28 | $5.00M | BUY | 57.64% | 126.27K | Aug 19 | ||
Nov 29, 2021 | HEAD R&D, CSO | 3.78K | $79.33 | $299.87K | BUY | 6.11% | 65.68K | Nov 24 | ||
Nov 17, 2021 | PRESIDENT & CEO | 25.03K | $79.94 | $2.00M | BUY | 7.36% | 365.08K | Nov 17 | ||
Mar 10, 2021 | DIRECTOR | 0.00 | $64.03 | -$217.30K | SELL-OPTIONS | 0.00% | 140.52K | Mar 10 | ||
Mar 10, 2021 | DIRECTOR | 0.00 | $59.22 | -$485.90K | SELL-OPTIONS | 0.00% | 16.52K | Mar 08 | ||
Dec 14, 2020 | — | 0.00 | $118.22 | -$104.31K | OPTION EXERCISE | 0.00% | 8.14K | Dec 11 | ||
Dec 10, 2020 | — | 0.00 | $94.80 | -$146.70K | OPTION EXERCISE | 0.00% | 8.14K | Dec 08 |
Parcourir transactions d'initiés sur toutes les actions.